UnitedHealth Group (UNH) to Release Quarterly Earnings on Thursday


Share on StockTwits

UnitedHealth Group (NYSE:UNH) will be issuing its quarterly earnings data before the market opens on Thursday, April 15th. Analysts expect the company to announce earnings of $4.41 per share for the quarter. Individual that wish to register for the company’s earnings conference call can do so using this link.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, January 19th. The healthcare conglomerate reported $2.52 EPS for the quarter, beating analysts’ consensus estimates of $2.39 by $0.13. UnitedHealth Group had a return on equity of 27.53% and a net margin of 6.62%. The firm had revenue of $65.47 billion for the quarter, compared to the consensus estimate of $64.98 billion. During the same quarter in the previous year, the company posted $3.90 earnings per share. The business’s quarterly revenue was up 7.5% compared to the same quarter last year. On average, analysts expect UnitedHealth Group to post $17 EPS for the current fiscal year and $18 EPS for the next fiscal year.

Shares of UNH stock opened at $374.50 on Wednesday. UnitedHealth Group has a 12 month low of $267.00 and a 12 month high of $380.50. The company has a quick ratio of 0.82, a current ratio of 0.82 and a debt-to-equity ratio of 0.59. The company has a market cap of $354.02 billion, a PE ratio of 21.51, a price-to-earnings-growth ratio of 1.55 and a beta of 0.74. The business’s 50 day moving average is $357.08 and its two-hundred day moving average is $341.57.

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 23rd. Stockholders of record on Monday, March 15th were paid a $1.25 dividend. The ex-dividend date of this dividend was Friday, March 12th. This represents a $5.00 annualized dividend and a dividend yield of 1.34%. UnitedHealth Group’s dividend payout ratio is presently 33.09%.

In other UnitedHealth Group news, Director Richard T. Burke sold 5,000 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, February 11th. The stock was sold at an average price of $335.80, for a total transaction of $1,679,000.00. Following the sale, the director now directly owns 153,953 shares in the company, valued at approximately $51,697,417.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Richard T. Burke sold 4,000 shares of the firm’s stock in a transaction on Monday, March 15th. The stock was sold at an average price of $353.32, for a total transaction of $1,413,280.00. Following the transaction, the director now directly owns 153,953 shares of the company’s stock, valued at $54,394,673.96. The disclosure for this sale can be found here. Insiders have sold a total of 9,619 shares of company stock valued at $3,292,774 in the last ninety days. Corporate insiders own 0.80% of the company’s stock.

An institutional investor recently bought a new position in UnitedHealth Group stock. OLD Mission Capital LLC bought a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 1,409 shares of the healthcare conglomerate’s stock, valued at approximately $439,000. 86.03% of the stock is owned by institutional investors and hedge funds.

A number of equities research analysts recently commented on UNH shares. Mizuho upped their price objective on UnitedHealth Group from $380.00 to $394.00 and gave the company a “buy” rating in a report on Friday, April 9th. Deutsche Bank Aktiengesellschaft upped their price objective on UnitedHealth Group from $404.00 to $409.00 and gave the company a “buy” rating in a research note on Thursday, January 21st. Truist boosted their target price on shares of UnitedHealth Group from $400.00 to $420.00 in a research report on Tuesday, January 5th. Bank of America reiterated a “buy” rating and set a $415.00 price target on shares of UnitedHealth Group in a research report on Thursday, January 21st. Finally, Barclays restated a “buy” rating and set a $405.00 price objective on shares of UnitedHealth Group in a research report on Sunday, January 17th. Five analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the stock. UnitedHealth Group presently has an average rating of “Buy” and a consensus price target of $388.45.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, Children's Health Insurance Program, and health care programs; medical and dental benefits; and health care delivery.

Featured Story: Day Trading

Earnings History for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.